225 related articles for article (PubMed ID: 10784014)
1. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
Miric A; Lombardi P; Sculco TP
Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
[TBL] [Abstract][Full Text] [Related]
2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
4. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
5. Advances in DVT prophylaxis and management in major orthopaedic surgery.
Hardwick ME; Colwell CW
Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
[TBL] [Abstract][Full Text] [Related]
6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
7. DVT prophylaxis in total joint reconstruction.
Sheth NP; Lieberman JR; Della Valle CJ
Orthop Clin North Am; 2010 Apr; 41(2):273-80. PubMed ID: 20399366
[TBL] [Abstract][Full Text] [Related]
8. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
9. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Brookenthal KR; Freedman KB; Lotke PA; Fitzgerald RH; Lonner JH
J Arthroplasty; 2001 Apr; 16(3):293-300. PubMed ID: 11307125
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
Li XL; Lu WJ; Yu NS
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
[TBL] [Abstract][Full Text] [Related]
12. Rationale for thromboprophylaxis in lower joint arthroplasty.
Colwell CW
Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
[TBL] [Abstract][Full Text] [Related]
13. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
[TBL] [Abstract][Full Text] [Related]
14. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
15. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
[TBL] [Abstract][Full Text] [Related]
17. [A combination of arteriovenous impulse system and low-molecular-weight heparins calcium for prophylaxis of deep venous thrombosis following total knee arthroplasty].
Cao J; Wang J; Zhang H; Wang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):538-40. PubMed ID: 20540254
[TBL] [Abstract][Full Text] [Related]
18. Prevention of venous thromboembolism in high-risk surgical and medical patients.
Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
[TBL] [Abstract][Full Text] [Related]
19. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
[TBL] [Abstract][Full Text] [Related]
20. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]